Skip to main content
PMC home page
Microbiological Reviews logoLink to Microbiological Reviews
. 1983 Mar;47(1):46–83. doi: 10.1128/mr.47.1.46-83.1983

Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

P W Taylor
PMCID: PMC281561  PMID: 6343827

Full text

PDF
83

Images in this article

54Image
on p.54

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDRIOLE V. T., EPSTEIN F. H. PREVENTION OF PYELONEPHRITIS BY WATER DIURESIS: EVIDENCE FOR THE ROLE OF MEDULLARY HYPERTONICITY IN PROMOTING RENAL INFECTION. J Clin Invest. 1965 Jan;44:73–79. doi: 10.1172/JCI105128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Achtman M., Kennedy N., Skurray R. Cell--cell interactions in conjugating Escherichia coli: role of traT protein in surface exclusion. Proc Natl Acad Sci U S A. 1977 Nov;74(11):5104–5108. doi: 10.1073/pnas.74.11.5104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Acquatella H., Little P. J., de Wardener H. E., Coleman J. C. The effect of urine osmolality and pH on the bactericidal activity of plasma. Clin Sci. 1967 Dec;33(3):471–480. [PubMed] [Google Scholar]
  4. Adinolfi M., Glynn A. A., Lindsay M., Milne C. M. Serological properties of gamma-A antibodies to Escherichia coli present in human colostrum. Immunology. 1966 Jun;10(6):517–526. [PMC free article] [PubMed] [Google Scholar]
  5. Akiyama Y., Inoue K. Isolation and properties of complement-resistant strains of Escherichia coli K-12. Infect Immun. 1977 Nov;18(2):446–453. doi: 10.1128/iai.18.2.446-453.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Allen R. J., Scott G. K. Human serum complement requirements for bacterial killing and protoplast lysis of Escherichia coli ML308 225. J Gen Microbiol. 1981 Mar;123(1):179–181. doi: 10.1099/00221287-123-1-179. [DOI] [PubMed] [Google Scholar]
  7. Alper C. A., Abramson N., Johnston R. B., Jr, Jandl J. H., Rosen F. S. Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N Engl J Med. 1970 Feb 12;282(7):350–354. doi: 10.1056/nejm197002122820701. [DOI] [PubMed] [Google Scholar]
  8. Archer G., Fekety F. R. Experimental endocarditis due to Pseudomonas aeruginosa. I. Description of a model. J Infect Dis. 1976 Jul;134(1):1–7. doi: 10.1093/infdis/134.1.1. [DOI] [PubMed] [Google Scholar]
  9. Avril M. F., Lebas J., Autran B., Modai J. Méningite à méningocoques récidivante associée à un déficit en 6e composant du complément. Nouv Presse Med. 1981 Oct 17;10(37):3057–3059. [PubMed] [Google Scholar]
  10. BEESON P. B., ROWLEY D. The anticomplementary effect of kidney tissue; its association with ammonia production. J Exp Med. 1959 Nov 1;110:685–697. doi: 10.1084/jem.110.5.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bader J., Teuber M. Action of polymyxin B on bacterial membranes. 1. Binding to the O-antigenic lipopolysaccharide of Salmonella typhimurium. Z Naturforsch C. 1973 Jul-Aug;28(7):422–430. [PubMed] [Google Scholar]
  12. Beckerdite-Quagliata S., Simberkoff M., Elsbach P. Effects of human and rabbit serum on viability, permeability, and envelope lipids of Serratia marcescens. Infect Immun. 1975 Apr;11(4):758–766. doi: 10.1128/iai.11.4.758-766.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Betz S. J., Isliker H. Antibody-independent interactions between Escherichia coli J5 and human complement components. J Immunol. 1981 Nov;127(5):1748–1754. [PubMed] [Google Scholar]
  14. Betz S. J., Page N., Estrade C., Isliker H. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement. J Immunol. 1982 Feb;128(2):707–711. [PubMed] [Google Scholar]
  15. Bhakdi S., Bjerrum O. J., Rother U., Knüfermann H., Wallach D. F. Immunochemical analyses of membrane-bound complement. Detection of the terminal complement complex and its similarity to "intrinsic" erythrocyte membrane proteins. Biochim Biophys Acta. 1975 Sep 16;406(1):21–35. doi: 10.1016/0005-2736(75)90039-5. [DOI] [PubMed] [Google Scholar]
  16. Bhakdi S., Tranum-Jensen J. Molecular nature of the complement lesion. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5655–5659. doi: 10.1073/pnas.75.11.5655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Binns M. M., Davies D. L., Hardy K. G. Cloned fragments of the plasmid ColV,I-K94 specifying virulence and serum resistance. Nature. 1979 Jun 28;279(5716):778–781. doi: 10.1038/279778a0. [DOI] [PubMed] [Google Scholar]
  18. Binns M. M., Mayden J., Levine R. P. Further characterization of complement resistance conferred on Escherichia coli by the plasmid genes traT of R100 and iss of ColV,I-K94. Infect Immun. 1982 Feb;35(2):654–659. doi: 10.1128/iai.35.2.654-659.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Bjornson A. B., Michael J. G. Biological Activities of Rabbit Immunoglobulin M and Immunoglobulin G Antibodies to Pseudomonas aeruginosa. Infect Immun. 1970 Oct;2(4):453–461. doi: 10.1128/iai.2.4.453-461.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Björkstén B., Bortolussi R., Gothefors L., Quie P. G. Interaction of E. coli strains with human serum: lack of relationship to K1 antigen. J Pediatr. 1976 Dec;89(6):892–897. doi: 10.1016/s0022-3476(76)80592-6. [DOI] [PubMed] [Google Scholar]
  21. Björkstén B., Kaijser B. Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria. Infect Immun. 1978 Nov;22(2):308–311. doi: 10.1128/iai.22.2.308-311.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Blachman U., Clark W. R., Pickett M. J. Radiobacteriolysis: a new technique using chromium-51 for assaying anti-Vibrio cholerae antibodies. Infect Immun. 1973 Jan;7(1):53–61. doi: 10.1128/iai.7.1.53-61.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Borsos T., Rapp H. J. Complement fixation on cell surfaces by 19S and 7S antibodies. Science. 1965 Oct 22;150(3695):505–506. doi: 10.1126/science.150.3695.505. [DOI] [PubMed] [Google Scholar]
  24. CEPPELLINI R., LANDY M. Suppression of blood group agglutinability of human erythrocytes by certain bacterial polysaccharides. J Exp Med. 1963 Mar 1;117:321–338. doi: 10.1084/jem.117.3.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. CHERNEW I., BRAUDE A. I. Depression of phagocytosis by solutes in concentrations found in the kidney and urine. J Clin Invest. 1962 Oct;41:1945–1953. doi: 10.1172/JCI104652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. COLLINS F. M. THE EFFECT OF THE GROWTH RATE ON THE COMPOSITION OF S. ENTERITIDIS CELL WALLS. Aust J Exp Biol Med Sci. 1964 Apr;42:255–262. doi: 10.1038/icb.1964.27. [DOI] [PubMed] [Google Scholar]
  27. Carroll E. J., Jasper D. E. Bactericidal activity of standard bovine serum against coliform bacteria isolated from udders and the environment of dairy cows. Am J Vet Res. 1977 Dec;38(12):2019–2022. [PubMed] [Google Scholar]
  28. Carroll S. F., Martinez R. J. Antibacterial peptide from normal rabbit serum. 2. Compositional microanalysis. Biochemistry. 1981 Oct 13;20(21):5981–5987. doi: 10.1021/bi00524a009. [DOI] [PubMed] [Google Scholar]
  29. Carroll S. F., Martinez R. J. Antibacterial peptide from normal rat serum. 1. Isolation from whole serum, activity, and microbicidal spectrum. Biochemistry. 1981 Oct 13;20(21):5973–5981. doi: 10.1021/bi00524a008. [DOI] [PubMed] [Google Scholar]
  30. Casciato D. A., Rosenblatt J. E., Bluestone R., Goldberg L. S., Finegold S. M. Susceptibility of isolates of Bacteroides to the bactericidal activity of normal human serum. J Infect Dis. 1979 Jul;140(1):109–113. doi: 10.1093/infdis/140.1.109. [DOI] [PubMed] [Google Scholar]
  31. Chedid L., Parant M., Parant F., Boyer F. A proposed mechanism for natural immunity to enterobacterial pathogens. J Immunol. 1968 Feb;100(2):292–306. [PubMed] [Google Scholar]
  32. Cheng S., Thomas J. K., Kulpa C. F. Dynamics of pyrene fluorescence in Escherichia coli membrane vesicles. Biochemistry. 1974 Mar 12;13(6):1135–1139. doi: 10.1021/bi00703a013. [DOI] [PubMed] [Google Scholar]
  33. Chester I. R., Meadow P. M. Heterogeneity of the lipopolysaccharide from Pseudomonas aeruginosa. Eur J Biochem. 1975 Oct 15;58(2):273–282. doi: 10.1111/j.1432-1033.1975.tb02373.x. [DOI] [PubMed] [Google Scholar]
  34. Clas F., Loos M. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera. Immunology. 1980 Aug;40(4):547–556. [PMC free article] [PubMed] [Google Scholar]
  35. Cobbs C. G., Kaye D. Antibacterial mechanisms in the urinary bladder. Yale J Biol Med. 1967 Oct;40(2):93–108. [PMC free article] [PubMed] [Google Scholar]
  36. Cohen I. R., Norins L. C. Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M. Science. 1966 May 27;152(3726):1257–1259. doi: 10.1126/science.152.3726.1257. [DOI] [PubMed] [Google Scholar]
  37. Collins F. M. Serum mediated killing of three group D salmonellas. J Gen Microbiol. 1967 Feb;46(2):247–253. doi: 10.1099/00221287-46-2-247. [DOI] [PubMed] [Google Scholar]
  38. Crombie L. B., Muschel L. H. Quantitative studies on spheroplast formation by the complement system and lysozyme on gram negative bacteria. Proc Soc Exp Biol Med. 1967 Apr;124(4):1029–1033. doi: 10.3181/00379727-124-31915. [DOI] [PubMed] [Google Scholar]
  39. DAVIS S. D., WEDGWOOD R. J. KINETICS OF THE BACTERICIDAL ACTION OF NORMAL SERUM ON GRAM-NEGATIVE BACTERIA. J Immunol. 1965 Jul;95:75–79. [PubMed] [Google Scholar]
  40. DOGGETT R. G., HARRISON G. M., WALLIS E. S. COMPARISON OF SOME PROPERTIES OF PSEUDOMONAS AERUGINOSA ISOLATED FROM INFECTIONS IN PERSONS WITH AND WITHOUT CYSTIC FIBROSIS. J Bacteriol. 1964 Feb;87:427–431. doi: 10.1128/jb.87.2.427-431.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Dahl C. E., Levine R. P. Electron spin resonance studies on interaction of complement proteins with erythrocyte membranes. Proc Natl Acad Sci U S A. 1978 Oct;75(10):4930–4934. doi: 10.1073/pnas.75.10.4930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Davies D. L., Falkiner F. R., Hardy K. G. Colicin V production by clinical isolates of Escherichia coli. Infect Immun. 1981 Feb;31(2):574–579. doi: 10.1128/iai.31.2.574-579.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. DeMatteo C. S., Hammer M. C., Baltch A. L., Smith R. P., Sutphen N. T., Michelsen P. B. Susceptibility of Pseudomonas aeruginosa to serum bactericidal activity. A comparison of three methods with clinical correlations. J Lab Clin Med. 1981 Oct;98(4):511–518. [PubMed] [Google Scholar]
  44. Dlabac V. The sensitivity of smooth and rough mutants of Salmonella typhimurium to bactericidal and bacteriolytic action of serum, lysozyme and to phagocytosis. Folia Microbiol (Praha) 1968;13(5):439–449. doi: 10.1007/BF02869196. [DOI] [PubMed] [Google Scholar]
  45. Domingue G. J., Neter E. Opsonizing and bactericidal activity of antibodies against common antigen of Enterobacteriaceae. J Bacteriol. 1966 Jan;91(1):129–133. doi: 10.1128/jb.91.1.129-133.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Donaldson D. M., Roberts R. R., Larsen H. S., Tew J. G. Interrelationship between serum beta-lysin, lysozyme, and the antibody-complement system in killing Escherichia coli. Infect Immun. 1974 Sep;10(3):657–666. doi: 10.1128/iai.10.3.657-666.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Durack D. T., Beeson P. B. Protective role of complement in experimental Escherichia coli endocarditis. Infect Immun. 1977 Apr;16(1):213–217. doi: 10.1128/iai.16.1.213-217.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. EISEN H. N., SISKIND G. W. VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE. Biochemistry. 1964 Jul;3:996–1008. doi: 10.1021/bi00895a027. [DOI] [PubMed] [Google Scholar]
  49. Eddie D. S., Schulkind M. L., Robbins J. B. The isolation and biologic activities of purified secretory IgA and IgG anti-Salmonella typhimurium "O" antibodies from rabbit intestinal fluid and colostrum. J Immunol. 1971 Jan;106(1):181–190. [PubMed] [Google Scholar]
  50. Eisenstein B. I., Lee T. J., Sparling P. F. Penicillin sensitivity and serum resistance are independent attributes of strains of Neisseria gonorrhoeae causing disseminated gonococcal infection. Infect Immun. 1977 Mar;15(3):834–841. doi: 10.1128/iai.15.3.834-841.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Elgefors B., Olling S. The significance of serum-sensitive bacilli in gram-negative bacteremia. Scand J Infect Dis. 1978;10(3):203–207. doi: 10.3109/inf.1978.10.issue-3.08. [DOI] [PubMed] [Google Scholar]
  52. Esser A. F., Bartholomew R. M., Jensen F. C., Müller-Eberhard H. J. Disassembly of viral membranes by complement independent of channel formation. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5843–5847. doi: 10.1073/pnas.76.11.5843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Esser A. F., Kolb W. P., Podack E. R., Müller-Eberhard H. J. Molecular reorganization of lipid bilayers by complement: a possible mechanism for membranolysis. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1410–1414. doi: 10.1073/pnas.76.3.1410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. FOGELSON S. J., ROSS A., LOBSTEIN O. E. A method for the quantitative determination of lysozyme activity in blood. Am J Dig Dis. 1954 Nov;21(11):327–331. doi: 10.1007/BF02883952. [DOI] [PubMed] [Google Scholar]
  55. Feingold D. S., Goldman J. N., Kuritz H. M. Locus of the action of serum and the role of lysozyme in the serum bactericidal reaction. J Bacteriol. 1968 Dec;96(6):2118–2126. doi: 10.1128/jb.96.6.2118-2126.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Feingold D. S., Goldman J. N., Kuritz H. M. Locus of the lethal event in the serum bactericidal reaction. J Bacteriol. 1968 Dec;96(6):2127–2131. doi: 10.1128/jb.96.6.2127-2131.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Feingold D. S., HsuChen C. C., Sud I. J. Basis for the selectivity of action of the polymyxin antibiotics on cell membranes. Ann N Y Acad Sci. 1974 May 10;235(0):480–492. doi: 10.1111/j.1749-6632.1974.tb43285.x. [DOI] [PubMed] [Google Scholar]
  58. Feingold D. S. The serum bactericidal reaction. IV. Phenotypic conversion of Escherichia coli from serum-resistance to serum-sensitivity by diphenylamine. J Infect Dis. 1969 Oct;120(4):437–444. doi: 10.1093/infdis/120.4.437. [DOI] [PubMed] [Google Scholar]
  59. Ferrante A., Thong Y. H. Inhibition of serum bactericidal activity by bilirubin. Immunol Lett. 1982 Feb;4(2):103–105. doi: 10.1016/0165-2478(82)90008-6. [DOI] [PubMed] [Google Scholar]
  60. Fields K. L., Luria S. E. Effects of colicins E1 and K on transport systems. J Bacteriol. 1969 Jan;97(1):57–63. doi: 10.1128/jb.97.1.57-63.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Fierer J., Finley F., Braude A. I. A plaque assay on agar for detection of gram-negative bacilli sensitive to complement. J Immunol. 1972 Nov;109(5):1156–1158. [PubMed] [Google Scholar]
  62. Fierer J., Finley F., Braude A. I. Release of 51Cr-endotoxin from bacteria as an assay of serum bactericidal activity. J Immunol. 1974 Jun;112(6):2184–2192. [PubMed] [Google Scholar]
  63. Fierer J., Finley F. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver. J Clin Invest. 1979 May;63(5):912–921. doi: 10.1172/JCI109391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Fierer J., Finley F. Lethal effect of complement and lysozyme on polymyxin-treated, serum-resistant gram-negative bacilli. J Infect Dis. 1979 Oct;140(4):581–589. doi: 10.1093/infdis/140.4.581. [DOI] [PubMed] [Google Scholar]
  65. Fietta A., Romero E., Siccardi A. G. Effect of some R factors on the sensitivity of rough Enterobacteriaceae to human serum. Infect Immun. 1977 Nov;18(2):278–282. doi: 10.1128/iai.18.2.278-282.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Fujita T. The activation mechanism of human complement system by immune precipitate formed with rabbit IgG antibody. Microbiol Immunol. 1979;23(10):1023–1031. doi: 10.1111/j.1348-0421.1979.tb00532.x. [DOI] [PubMed] [Google Scholar]
  67. Füst G., Petrás G., Ujhelvi E. Activation of the complement system during infections due to gram-negative bacteria. Clin Immunol Immunopathol. 1976 May;5(3):293–302. doi: 10.1016/0090-1229(76)90036-2. [DOI] [PubMed] [Google Scholar]
  68. GITLIN D., ROSEN F. S., MICHAEL J. G. Transient 19S gammaglobulin deficiency in the newborn infant, and its significance. Pediatrics. 1963 Feb;31:197–208. [PubMed] [Google Scholar]
  69. Galanos C., Lüderitz O. The role of the physical state of lipopolysaccharides in the interaction with complement. High molecular weight as prerequisite for the expression of anti-complementary activity. Eur J Biochem. 1976 Jun 1;65(2):403–408. doi: 10.1111/j.1432-1033.1976.tb10354.x. [DOI] [PubMed] [Google Scholar]
  70. Galanos C., Lüderitz O., Westphal O. A new method for the extraction of R lipopolysaccharides. Eur J Biochem. 1969 Jun;9(2):245–249. doi: 10.1111/j.1432-1033.1969.tb00601.x. [DOI] [PubMed] [Google Scholar]
  71. Gemsa D., Davis S. D., Wedgwood R. J. Lysozyme and serum bactericidal action. Nature. 1966 May 28;210(5039):950–951. doi: 10.1038/210950a0. [DOI] [PubMed] [Google Scholar]
  72. Gewurz H., Shin H. S., Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components. J Exp Med. 1968 Nov 1;128(5):1049–1057. doi: 10.1084/jem.128.5.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Giavedoni E. B., Mason R. P., Dalmasso A. P. Complement-induced modifications in membrane fluidity: studies with resealed and glutaraldehyde-treated erythrocyte membrane ghosts. J Immunol. 1978 Jun;120(6):2003–2007. [PubMed] [Google Scholar]
  74. Glynn A. A., Brumfitt W., Howard C. J. K antigens of Escherichia coli and renal involvement in urinary-tract infections. Lancet. 1971 Mar 13;1(7698):514–516. [PubMed] [Google Scholar]
  75. Glynn A. A., Howard C. J. The sensitivity to complement of strains of Escherichia coli related to their K antigens. Immunology. 1970 Mar;18(3):331–346. [PMC free article] [PubMed] [Google Scholar]
  76. Glynn A. A., Milne C. M. A kinetic study of the bacteriolytic and bactericidal action of human serum. Immunology. 1967 Jun;12(6):639–653. [PMC free article] [PubMed] [Google Scholar]
  77. Glynn A. A. The complement lysozyme sequence in immune bacteriolysis. Immunology. 1969 Apr;16(4):463–471. [PMC free article] [PubMed] [Google Scholar]
  78. Glynn A. A., Ward M. E. Nature and Heterogeneity of the Antigens of Neisseria gonorrhoeae Involved in the Serum Bactericidal Reaction. Infect Immun. 1970 Aug;2(2):162–168. doi: 10.1128/iai.2.2.162-168.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Goldman J. N., Austen K. F. Reaction mechanisms of nascent C567 (reactive lysis). II. Killing of a rough form of Escherichia coli by C567, C8, and C9. J Infect Dis. 1974 Apr;129(4):444–450. doi: 10.1093/infdis/129.4.444. [DOI] [PubMed] [Google Scholar]
  80. Goldman J. N., Ruddy S., Austen K. F., Feingold D. S. The serum bactericidal reaction. 3. Antibody and complement requirements for killing a rough Escherichia coli. J Immunol. 1969 Jun;102(6):1379–1387. [PubMed] [Google Scholar]
  81. Goldman R. C., Leive L. Heterogeneity of antigenic-side-chain length in lipopolysaccharide from Escherichia coli 0111 and Salmonella typhimurium LT2. Eur J Biochem. 1980;107(1):145–153. doi: 10.1111/j.1432-1033.1980.tb04635.x. [DOI] [PubMed] [Google Scholar]
  82. Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med. 1969 Jun 1;129(6):1327–1348. doi: 10.1084/jem.129.6.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Gordon J., Whitehead H. R., Wormall A. The Action of Ammonia on Complement. The Fourth Component. Biochem J. 1926;20(5):1028–1035. doi: 10.1042/bj0201028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Gower P. E., Taylor P. W., Koutsaimanis K. G., Roberts A. P. Serum bactericidal activity in patients with upper and lower urinary tract infections. Clin Sci. 1972 Jul;43(1):13–22. doi: 10.1042/cs0430013. [DOI] [PubMed] [Google Scholar]
  85. Griffiss J. M., Bertram M. A. Immunoepidemiology of meningococcal disease in military recruits. II. Blocking of serum bactericidal activity by circulating IgA early in the course of invasive disease. J Infect Dis. 1977 Dec;136(6):733–739. doi: 10.1093/infdis/136.6.733. [DOI] [PubMed] [Google Scholar]
  86. Griffiths E. Mechanism of action of specific antiserum on Pasteurella septica. Selective inhibition of net macromolecular synthesis and its reversal by iron compounds. Eur J Biochem. 1971 Nov 11;23(1):69–76. doi: 10.1111/j.1432-1033.1971.tb01593.x. [DOI] [PubMed] [Google Scholar]
  87. Griffiths E. Metabolically controlled killing of Pasteurella septica by antibody and complement. Biochim Biophys Acta. 1974 Oct 8;362(3):598–601. doi: 10.1016/0304-4165(74)90157-3. [DOI] [PubMed] [Google Scholar]
  88. Gupta A. K., Rao K. M. A simple bactericidal antibody test for sero-diagnosis of typhoid fever. J Immunol Methods. 1981;42(1):121–125. doi: 10.1016/0022-1759(81)90231-3. [DOI] [PubMed] [Google Scholar]
  89. Gutschik E., Norwood R. S., Møller S., Olling S. Experimental endocarditis in rabbits. 4. Experiments with Serratia marcescens: on the significance of serum susceptibility and proteolytic capacity of the strains and the influence of an indwelling catheter. Acta Pathol Microbiol Scand B. 1980 Oct;88(5):269–276. [PubMed] [Google Scholar]
  90. Guttman R. M., Waisbren B. A. Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection. Clin Exp Immunol. 1975 Jan;19(1):121–130. [PMC free article] [PubMed] [Google Scholar]
  91. HIRSCH J. G. Comparative bactericidal activities of blood serum and plasma serum. J Exp Med. 1960 Jul 1;112:15–22. doi: 10.1084/jem.112.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Haeney M. R., Thompson R. A., Faulkner J., Mackintosh P., Ball A. P. Recurrent bacterial meningitis in patients with genetic defects of terminal complement components. Clin Exp Immunol. 1980 Apr;40(1):16–24. [PMC free article] [PubMed] [Google Scholar]
  93. Haimovich J., Sela M. Inactivation of bacteriophage T4, of poly-D-alanyl bacteriophage and of penicilloyl bacteriophage by immunospecifically isolated IgM and IgG antibodies. J Immunol. 1969 Jul;103(1):45–55. [PubMed] [Google Scholar]
  94. Hall W. H., Manion R. E., Zinneman H. H. Blocking serum lysis of Brucella abortus by hyperimmune rabbit immunoglubulin A. J Immunol. 1971 Jul;107(1):41–46. [PubMed] [Google Scholar]
  95. Hand W. L., King N. L. Deficiency of serum bactericidal activity against Salmonella typhimurium in sickle cell anaemia. Clin Exp Immunol. 1977 Nov;30(2):262–270. [PMC free article] [PubMed] [Google Scholar]
  96. Harriman G. R., Esser A. F., Podack E. R., Wunderlich A. C., Braude A. I., Lint T. F., Curd J. G. The role of C9 in complement-mediated killing of Neisseria. J Immunol. 1981 Dec;127(6):2386–2390. [PubMed] [Google Scholar]
  97. Heddle R. J., Knop J., Steele E. J., Rowley D. The effect of lysozyme on the complement-dependent bactericidal action of different antibody classes. Immunology. 1975 Jun;28(6):1061–1066. [PMC free article] [PubMed] [Google Scholar]
  98. Heddle R. J., Rowley D. Dog immunoglobulins. II. The antibacterial properties of dog IgA, IgM and IgG antibodies to Vibrio cholerae. Immunology. 1975 Jul;29(1):197–208. [PMC free article] [PubMed] [Google Scholar]
  99. Henkel W., Commichau R. Serumresistenz und "Nephropathogenität" antigenetisch definierter Stämme von E. coli. 3. Experimentelle Pyelonephritis mit unterschiedlich serumresistenten Keimen. Z Med Mikrobiol Immunol. 1971;156(3):297–304. [PubMed] [Google Scholar]
  100. Henkel W. Serumresistenz und "Nephropathogenität" antigenetisch definierter Stämme von E. coli. II. Verhalten unterschiedlich serumresistenter Keime in vitro. Z Med Mikrobiol Immunol. 1971;156(3):284–296. [PubMed] [Google Scholar]
  101. Hildebrandt J. F., Mayer L. W., Wang S. P., Buchanan T. M. Neisseria gonorrhoeae acquire a new principal outer-membrane protein when transformed to resistance to serum bactericidal activity. Infect Immun. 1978 Apr;20(1):267–272. doi: 10.1128/iai.20.1.267-272.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Howard C. J., Glynn A. A. The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement. Immunology. 1971 May;20(5):767–777. [PMC free article] [PubMed] [Google Scholar]
  103. Hughes C., Phillips R., Roberts A. P. Serum resistance among Escherichia coli strains causing urinary tract infection in relation to O type and the carriage of hemolysin, colicin, and antibiotic resistance determinants. Infect Immun. 1982 Jan;35(1):270–275. doi: 10.1128/iai.35.1.270-275.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Inoue K., Kinoshita T., Okada M., Akiyama Y. Release of phospholipids from complement-mediated lesions on the surface structure of Escherichia coli. J Immunol. 1977 Jul;119(1):65–72. [PubMed] [Google Scholar]
  105. Inoue K., Takamizawa A., Kurimura T., Yomemasu K. Studies on the immune bacteriolysis. 13. Leakage of enzymes from Escherichia coli during immune bacteriolysis. Biken J. 1968 Sep;11(3):193–201. [PubMed] [Google Scholar]
  106. Inoue K., Takamizawa A., Yano K., Amano T. Chemical studies on damages of Escherichia coli by the immune bactericidal reaction. I. Release and degradation of phospholipids from damaged bacteria. Biken J. 1974 Dec;17(4):127–134. [PubMed] [Google Scholar]
  107. Inoue K., Yano K., Amano T. Chemical studies on damages of Escherichea coli by the immune bactericidal reaction. II. Release of phosphatidylethanolamine from a phospholipase A-deficient mutant of E. coli during the immune bactericidal reaction. Biken J. 1974 Dec;17(4):135–140. [PubMed] [Google Scholar]
  108. Inoue K., Yonemasu K., Takamizawa A., Amano T. [Studies on the immune bacteriolysis. XIV. Requirement of all nine components of complement for immune bacteriolysis]. Biken J. 1968 Sep;11(3):203–206. [PubMed] [Google Scholar]
  109. Jain N. C., Lasmanis J. Phagocytosis of serum-resistant and serum-sensitive coliform bacteria (Klebsiella) by bovine neutrophils from blood and mastitic milk. Am J Vet Res. 1978 Mar;39(3):425–427. [PubMed] [Google Scholar]
  110. Jann B., Jann K., Schmidt G., Orskov I., Orskov F. Immunochemical studies of polysaccharide surface antigens of Escherichia coli 0100:K?(B):H2. Eur J Biochem. 1970 Jul;15(1):29–39. doi: 10.1111/j.1432-1033.1970.tb00972.x. [DOI] [PubMed] [Google Scholar]
  111. Jit Sud I., Feingold D. S. Detection of agents that alter the bacterial cell surface. Antimicrob Agents Chemother. 1975 Jul;8(1):34–37. doi: 10.1128/aac.8.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Joiner K. A., Hammer C. H., Brown E. J., Cole R. J., Frank M. M. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death. J Exp Med. 1982 Mar 1;155(3):797–808. doi: 10.1084/jem.155.3.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Joiner K. A., Hammer C. H., Brown E. J., Frank M. M. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane. J Exp Med. 1982 Mar 1;155(3):809–819. doi: 10.1084/jem.155.3.809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. KALMANSON G. M., HUBERT E., GUZE L. B. SERUM BACTERICIDAL ACTIVITY IN PATIENTS WITH PYELONEPHRITIS. Am J Med Sci. 1964 Sep;248:285–289. doi: 10.1097/00000441-196409000-00005. [DOI] [PubMed] [Google Scholar]
  115. KIMBALL H., GARCIA M., PETERSDORF R. G. THE EPIDEMIOLOGY OF NONENTERIC ESCHERICHIA COLI INFECTIONS. II. RELATIONSHIP OF PREVALENCE OF E. COLI IN URINARY INFECTIONS TO THE BACTERICIDAL EFFECT OF HUMAN SERUM. J Lab Clin Med. 1964 Jun;63:901–906. [PubMed] [Google Scholar]
  116. Kaijser B., Hanson L. A., Jodal U., Lidin-Janson G., Robbins J. B. Frequency of E. coli K antigens in urinary-tract infections in children. Lancet. 1977 Mar 26;1(8013):663–666. doi: 10.1016/s0140-6736(77)92111-0. [DOI] [PubMed] [Google Scholar]
  117. Kato K., Bito Y. Relationship between bactericidal action of complement and fluidity of cellular membranes. Infect Immun. 1978 Jan;19(1):12–17. doi: 10.1128/iai.19.1.12-17.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. King B. F., Biel M. L., Wilkinson B. J. Facile penetration of the Staphylococcus aureus capsule by lysostaphin. Infect Immun. 1980 Sep;29(3):892–896. doi: 10.1128/iai.29.3.892-896.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. King B. F., Wilkinson B. J. Binding of human immunoglobulin G to protein A in encapsulated Staphylococcus aureus. Infect Immun. 1981 Sep;33(3):666–672. doi: 10.1128/iai.33.3.666-672.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Kreutzer D. L., Vandermaten M., Buller C. S., Robertson D. C., Hirata A. A. Role of bacterial phospholipases in serum-mediated killing of Escherichia coli. Infect Immun. 1977 Oct;18(1):183–188. doi: 10.1128/iai.18.1.183-188.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Krishnapillai V. Uridinediphosphogalactose-4-epimerase deficiency in Salmonella typhimurium and its correction by plasmoid-borne galactose genes of Escherichia coli K-12: effects on mouse virulence, phagocytosis, and serum sensitivity. Infect Immun. 1971 Sep;4(3):177–188. doi: 10.1128/iai.4.3.177-188.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Lachmann P. J., Thompson R. A. Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med. 1970 Apr 1;131(4):643–657. doi: 10.1084/jem.131.4.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Landy M., Sanderson R. P., Jackson A. L. Humoral and cellular aspects of the immune response to the somatic antigen of Salmonella enteritidis. J Exp Med. 1965 Sep 1;122(3):483–504. doi: 10.1084/jem.122.3.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Lauf P. K. Immunological and physiological characteristics of the rapid immune hemolysis of neuraminidase-treated sheep red cells produced by fresh guinea pig serum. J Exp Med. 1975 Oct 1;142(4):974–988. doi: 10.1084/jem.142.4.974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Lee T. J., Utsinger P. D., Snyderman R., Yount W. J., Sparling P. F. Familial deficiency of the seventh component of complement associated with recurrent bacteremic infections due to Neisseria. J Infect Dis. 1978 Sep;138(3):359–368. doi: 10.1093/infdis/138.3.359. [DOI] [PubMed] [Google Scholar]
  126. Leive L. Release of lipopolysaccharide by EDTA treatment of E. coli. Biochem Biophys Res Commun. 1965 Nov 22;21(4):290–296. doi: 10.1016/0006-291x(65)90191-9. [DOI] [PubMed] [Google Scholar]
  127. Li C. K., Levine R. P. Molecular transport via the functional complement lesion. Mol Immunol. 1980 Dec;17(12):1465–1474. doi: 10.1016/0161-5890(80)90172-8. [DOI] [PubMed] [Google Scholar]
  128. Lindberg U., Hanson L. A., Jodal U., Lidin-Janson G., Lincoln K., Olling S. Asymptomatic bacteriuria in schoolgirls. II. Differences in escherichia coli causing asymptomatic bacteriuria. Acta Paediatr Scand. 1975 May;64(3):432–436. doi: 10.1111/j.1651-2227.1975.tb03860.x. [DOI] [PubMed] [Google Scholar]
  129. Linker A., Jones R. S. A new polysaccharide resembling alginic acid isolated from pseudomonads. J Biol Chem. 1966 Aug 25;241(16):3845–3851. [PubMed] [Google Scholar]
  130. Lint T. F., Zeitz H. J., Gewurz H. Inherited deficiency of the ninth component of complement in man. J Immunol. 1980 Nov;125(5):2252–2257. [PubMed] [Google Scholar]
  131. Loos M., Wellek B., Thesen R., Opferkuch W. Antibody-independent interaction of the first component of complement with Gram-negative bacteria. Infect Immun. 1978 Oct;22(1):5–9. doi: 10.1128/iai.22.1.5-9.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Lyman M. B., Steward J. P., Roantree R. J. Characterization of the virulence and antigenic structure of Salmonella typhimurium strains with lipopolysaccharide core defects. Infect Immun. 1976 Jun;13(6):1539–1542. doi: 10.1128/iai.13.6.1539-1542.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. MEYNELL G. G., SUBBAIAH T. V. Antibacterial mechanisms of the mouse gut. I. Kinetics of infection by Salmonella typhi-murium in normal and streptomycin-treated mice studied with abortive transductants. Br J Exp Pathol. 1963 Apr;44:197–208. [PMC free article] [PubMed] [Google Scholar]
  134. MICHAEL J. G., BRAUN W. Relationships between bacterial resistance to serum and penicillin. Proc Soc Exp Biol Med. 1958 Jan;97(1):104–107. doi: 10.3181/00379727-97-23658. [DOI] [PubMed] [Google Scholar]
  135. MICHAEL J. G., LANDY M. Endotoxic properties of gramnegative bacteria and their susceptibility to the lethal effect of normal serum. J Infect Dis. 1961 Jan-Feb;108:90–94. doi: 10.1093/infdis/108.1.90. [DOI] [PubMed] [Google Scholar]
  136. MICHAEL J. G., ROSEN F. S. ASSOCIATION OF "NATURAL" ANTIBODIES TO GRAM-NEGATIVE BACTERIA WITH THE GAMMA-1-MACROGLOBULINS. J Exp Med. 1963 Oct 1;118:619–626. doi: 10.1084/jem.118.4.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. MICHAEL J. G., WHITBY J. L., LANDY M. Increase in specific bactericidal antibodies after administration of endotoxin. Nature. 1961 Jul 15;191:296–297. doi: 10.1038/191296a0. [DOI] [PubMed] [Google Scholar]
  138. MICHAEL J. G., WHITBY J. L., LANDY M. Studies on natural antibodies to gram-negative bacteria. J Exp Med. 1962 Jan 1;115:131–146. doi: 10.1084/jem.115.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. MUSCHEL L. H. Bactericidal activity of normal serum against bacterial cultures. II. Activity against Eschericha coli strains. Proc Soc Exp Biol Med. 1960 Mar;103:632–636. doi: 10.3181/00379727-103-25619. [DOI] [PubMed] [Google Scholar]
  140. MUSCHEL L. H., CHAMBERLIN R. H., OSAWA E. Bactericidal activity of normal serum against bacterial cultures. I. Activity against Salmonella typhi strains. Proc Soc Exp Biol Med. 1958 Feb;97(2):376–382. doi: 10.3181/00379727-97-23748. [DOI] [PubMed] [Google Scholar]
  141. MUSCHEL L. H., TREFFERS H. P. Quantitative studies on the bactericidal actions of serum and complement. I. A rapid photometric growth assay for bactericidal activity. J Immunol. 1956 Jan;76(1):1–10. [PubMed] [Google Scholar]
  142. MYRVIK Q. N., WEISER R. S. Studies on antibacterial factors in mammalian tissues and fluids. I. A serum bactericidin for Bacillus subtilis. J Immunol. 1955 Jan;74(1):9–16. [PubMed] [Google Scholar]
  143. Martinez R. J., Carroll S. F. Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme. Infect Immun. 1980 Jun;28(3):735–745. doi: 10.1128/iai.28.3.735-745.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Mason T. G., Richardson G. Escherichia coli and the human gut: some ecological considerations. J Appl Bacteriol. 1981 Aug;51(1):1–16. doi: 10.1111/j.1365-2672.1981.tb00903.x. [DOI] [PubMed] [Google Scholar]
  145. Maw J., Meynell G. G. The true division and death rates of Salmonella typhimurium in the mouse spleen determined with superinfecting phage P22. Br J Exp Pathol. 1968 Dec;49(6):597–613. [PMC free article] [PubMed] [Google Scholar]
  146. Mayer M. M. Membrane damage by complement. Johns Hopkins Med J. 1981 Jun;148(6):243–258. [PubMed] [Google Scholar]
  147. McCabe W. R., Kaijser B., Olling S., Uwaydah M., Hanson L. A. Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis. 1978 Jul;138(1):33–41. doi: 10.1093/infdis/138.1.33. [DOI] [PubMed] [Google Scholar]
  148. McCutchan J. A., Katzenstein D., Norquist D., Chikami G., Wunderlich A., Braude A. I. Role of blocking antibody in disseminated gonococcal infection. J Immunol. 1978 Nov;121(5):1884–1888. [PubMed] [Google Scholar]
  149. McElree H., Pitcher J., Arnwine J. Transiently acquired serum resistance by cell-grown Escherichia coli. J Infect Dis. 1966 Apr;116(2):231–237. doi: 10.1093/infdis/116.2.231. [DOI] [PubMed] [Google Scholar]
  150. Medearis D. N., Jr, Camitta B. M., Heath E. C. Cell wall composition and virulence in Escherichia coli. J Exp Med. 1968 Sep 1;128(3):399–414. doi: 10.1084/jem.128.3.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Medhurst F. A., Glynn A. A. In vivo bactericidal activity of mouse complement against Escherichia coli. Br J Exp Pathol. 1970 Oct;51(5):498–506. [PMC free article] [PubMed] [Google Scholar]
  152. Melching L., Vas S. I. Effects of serum components on gram-negative bacteria during bactericidal reactions. Infect Immun. 1971 Jan;3(1):107–115. doi: 10.1128/iai.3.1.107-115.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Melching L., Vas S. I. The effects of serum components on the agglutination of Gram-negative bacteria. Can J Microbiol. 1970 Feb;16(2):121–124. doi: 10.1139/m70-020. [DOI] [PubMed] [Google Scholar]
  154. Michael J. G., Braun W. Analysis of sequential stages in serum bactericidal reactions. J Bacteriol. 1964 May;87(5):1067–1072. doi: 10.1128/jb.87.5.1067-1072.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Miler I., Vondrácek J., Hromádková L. The bactericidal activity of sera of healthy neonates and of newborns with hyperbilirubinaemia to Escherichia coli. Folia Microbiol (Praha) 1979;24(2):143–152. doi: 10.1007/BF02927298. [DOI] [PubMed] [Google Scholar]
  156. Miller T. E., North J. D. Editorial: Host response in urinary tract infections. Kidney Int. 1974 Mar;5(3):179–186. doi: 10.1038/ki.1974.22. [DOI] [PubMed] [Google Scholar]
  157. Miller T. E., Phillips S., Simpson I. J. Complement-mediated immune mechanisms in renal infection. II. Effect of decomplementation. Clin Exp Immunol. 1978 Jul;33(1):115–121. [PMC free article] [PubMed] [Google Scholar]
  158. Mittal K. R., Ingram D. G. Factors involved in bactericidal activity of sheep serum. Am J Vet Res. 1975 Aug;36(08):1183–1187. [PubMed] [Google Scholar]
  159. Moll A., Manning P. A., Timmis K. N. Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli. Infect Immun. 1980 May;28(2):359–367. doi: 10.1128/iai.28.2.359-367.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Montgomerie J. Z., Kalmanson G. M., Guze L. B. Leukocyte phagocytosis and serum bactericidal activity in chronic renal failure. Am J Med Sci. 1972 Nov;264(5):385–393. doi: 10.1097/00000441-197211000-00006. [DOI] [PubMed] [Google Scholar]
  161. Morrison D. C., Jacobs D. M. Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B. Infect Immun. 1976 Jan;13(1):298–301. doi: 10.1128/iai.13.1.298-301.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Morrison D. C., Kline L. F. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol. 1977 Jan;118(1):362–368. [PubMed] [Google Scholar]
  163. Munn C. B., Ishiguro E. E., Kay W. W., Trust T. J. Role of surface components in serum resistance of virulent Aeromonas salmonicida. Infect Immun. 1982 Jun;36(3):1069–1075. doi: 10.1128/iai.36.3.1069-1075.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Muschel L. H., Ahl L. A., Baron L. S. Effect of lysogeny on serum sensitivity. J Bacteriol. 1968 Dec;96(6):1912–1914. doi: 10.1128/jb.96.6.1912-1914.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Muschel L. H., Jackson J. E. The reactivity of serum against protoplasts and spheroplasts. J Immunol. 1966 Jul;97(1):46–51. [PubMed] [Google Scholar]
  166. Muschel L. H., Larsen L. J. Effect of hypertonic sucrose upon the immune bactericidal reaction. Infect Immun. 1970 Jan;1(1):51–55. doi: 10.1128/iai.1.1.51-55.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Muschel L. H., Larsen L. J. The sensitivity of smooth and rough gram-negative bacteria to the immune bactericidal reaction. Proc Soc Exp Biol Med. 1970 Jan;133(1):345–348. doi: 10.3181/00379727-133-34472. [DOI] [PubMed] [Google Scholar]
  168. Muschel L. H., Schmoker K. Activity of mitomycin C, other antibiotics, and serum against lysogenic bacteria. J Bacteriol. 1966 Oct;92(4):967–971. doi: 10.1128/jb.92.4.967-971.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. NOLLER E. C., HARTSELL S. E. Bacteriolysis of Enterobacteriaceae. I. Lysis by four lytic systems utilizing lysozyme. J Bacteriol. 1961 Mar;81:482–491. doi: 10.1128/jb.81.3.482-491.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. NOLLER E. C., HARTSELL S. E. Bacteriolysis of Enterobacteriaceae. II. Pre- and co-lytic treatments potentiating the action of lysozyme. J Bacteriol. 1961 Mar;81:492–499. doi: 10.1128/jb.81.3.492-499.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Nakano M., Kishimoto Y., Saito K. Spot method in agar for the quantitative assay of anti-Salmonella antibody. Jpn J Microbiol. 1968 Sep;12(3):364–366. doi: 10.1111/j.1348-0421.1968.tb00408.x. [DOI] [PubMed] [Google Scholar]
  172. Nelson B. W., Roantree R. J. Analyses of lipopolysaccharides extracted from penicillin-resistant, serum-sensitive salmonella mutants. J Gen Microbiol. 1967 Aug;48(2):179–188. doi: 10.1099/00221287-48-2-179. [DOI] [PubMed] [Google Scholar]
  173. Nikaido H., Takeuchi Y., Ohnishi S. I., Nakae T. Outer membrane of Salmonella typhimurium. Electron spin resonance studies. Biochim Biophys Acta. 1977 Feb 14;465(1):152–164. doi: 10.1016/0005-2736(77)90363-7. [DOI] [PubMed] [Google Scholar]
  174. Nonaka M., Yamaguchi N., Natsuume-Sakai S., Takahashi M. The complement system of rainbow trout (Salmo gairdneri). I. Identification of the serum lytic system homologous to mammalian complement. J Immunol. 1981 Apr;126(4):1489–1494. [PubMed] [Google Scholar]
  175. Norden C. W., Callerame M. L., Baum J. Haemophilus influenzae meningitis in an adult. A study of bactericidal antibodies and immunoglobulins. N Engl J Med. 1970 Jan 22;282(4):190–194. doi: 10.1056/NEJM197001222820404. [DOI] [PubMed] [Google Scholar]
  176. Normann B., Stendahl O., Tagesson C., Edebo L. Characteristics of the inhibition by rabbit immune serum of the bactericidal effect of cattle normal serum on Salmonella typhimurium 395 MRO. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(6):891–899. doi: 10.1111/j.0365-5563.1973.tb00016.x. [DOI] [PubMed] [Google Scholar]
  177. OSAWA E., MUSCHEL L. H. STUDIES RELATING TO THE SERUM RESISTANCE OF CERTAIN GRAM-NEGATIVE BACTERIA. J Exp Med. 1964 Jan 1;119:41–51. doi: 10.1084/jem.119.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Ogata R. T., Levine R. P. Characterization of complement resistance in Escherichia coli conferred by the antibiotic resistance plasmid R100. J Immunol. 1980 Oct;125(4):1494–1498. [PubMed] [Google Scholar]
  179. Olling S., Hanson L. A., Holmgren J., Jodal U., Lincoln K., Lindberg U. The bactericidal effect of normal human serum on E. coli strains from normals and from patients with urinary tract infections. Infection. 1973;1(1):24–28. doi: 10.1007/BF01638251. [DOI] [PubMed] [Google Scholar]
  180. Olling S., Jones K. V., Mackenzie R., Jones E. R., Hanson L. A., Asscher A. W. A four-year follow-up of schoolgirls with untreated covert bacteriuria: bacteriological aspects. Clin Nephrol. 1981 Oct;16(4):169–171. [PubMed] [Google Scholar]
  181. Olling S. Sensitivity of gram-negative bacilli to the serum bactericidal activity: a marker of the host-parasite relationship in acute and persisting infections. Scand J Infect Dis Suppl. 1977;(10):1–40. doi: 10.3109/inf.1977.9.suppl-10.01. [DOI] [PubMed] [Google Scholar]
  182. Opal S., Cross A., Gemski P. K antigen and serum sensitivity of rough Escherichia coli. Infect Immun. 1982 Sep;37(3):956–960. doi: 10.1128/iai.37.3.956-960.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Ormrod D. J., Miller T. E. Complement-mediated immune mechanisms in renal infection. Clin Exp Immunol. 1978 Jul;33(1):107–114. [PMC free article] [PubMed] [Google Scholar]
  184. Orskov I., Orskov F., Jann B., Jann K. Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol Rev. 1977 Sep;41(3):667–710. doi: 10.1128/br.41.3.667-710.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Orskov I., Sharma V., Orskov F. Genetic mapping of the K1 and K4 antigens (L) of Escherichia coli. Non-allelism of K(L) antigens with K antigens of O8:K27(A), O8:K8(L) and O9:K57(B). Acta Pathol Microbiol Scand B. 1976 Jun;84(3):125–131. [PubMed] [Google Scholar]
  186. Overath P., Brenner M., Gulik-Krzywicki T., Shechter E., Letellier L. Lipid phase transitions in cytoplasmic and outer membranes of Escherichia coli. Biochim Biophys Acta. 1975 May 6;389(2):358–369. doi: 10.1016/0005-2736(75)90328-4. [DOI] [PubMed] [Google Scholar]
  187. Peter G., Weigert M. B., Bissel A. R., Gold R., Kreutzer D., McLean R. H. Meningococcal meningitis in familial deficiency of the fifth component of complement. Pediatrics. 1981 Jun;67(6):882–886. [PubMed] [Google Scholar]
  188. Petersen B. H., Lammel C. J., Stites D. P., Brooks G. F. Human seminal plasma inhibition of complement. J Lab Clin Med. 1980 Oct;96(4):582–591. [PubMed] [Google Scholar]
  189. Petersen B. H., Lee T. J., Snyderman R., Brooks G. F. Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med. 1979 Jun;90(6):917–920. doi: 10.7326/0003-4819-90-6-917. [DOI] [PubMed] [Google Scholar]
  190. Pike R. M., Chandler C. H. Serological Properties of gammaG and gammaM Antibodies to the Somatic Antigen of Vibrio cholerae During the Course of Immunization of Rabbits. Infect Immun. 1971 Jun;3(6):803–809. doi: 10.1128/iai.3.6.803-809.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Pitt J. K-1 antigen of Escherichia coli: epidemiology and serum sensitivity of pathogenic strains. Infect Immun. 1978 Oct;22(1):219–224. doi: 10.1128/iai.22.1.219-224.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Podack E. R., Müller-Eberhard H. J. Membrane attack complex of complement. Evidence for its dimeric structure based on hybrid formation. J Biol Chem. 1981 Apr 10;256(7):3145–3148. [PubMed] [Google Scholar]
  193. Podack E. R., Tschopp J. Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement. Proc Natl Acad Sci U S A. 1982 Jan;79(2):574–578. doi: 10.1073/pnas.79.2.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Polk H. C., Miles A. A. The decisive period in the primary infection of muscle by Escherichia coli. Br J Exp Pathol. 1973 Feb;54(1):99–109. [PMC free article] [PubMed] [Google Scholar]
  195. Provonchee R. B., Zinner S. H. Rapid method for determining serum bactericidal activity. Appl Microbiol. 1974 Jan;27(1):185–186. doi: 10.1128/am.27.1.185-186.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. ROANTREE R. J., PAPPAS N. C. The survival of strains of enteric bacilli in the blood stream as related to their sensitivity to the bactericidal effect of serum. J Clin Invest. 1960 Jan;39:82–88. doi: 10.1172/JCI104031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. ROANTREE R. J., STEWARD J. P. MUTATIONS TO PENICILLIN RESISTANCE IN THE ENTEROBACTERIACEAE THAT AFFECT SENSITIVITY TO SERUM AND VIRULENCE FOR THE MOUSE. J Bacteriol. 1965 Mar;89:630–639. doi: 10.1128/jb.89.3.630-639.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. ROBBINS J. B., KENNY K., SUTER E. THE ISOLATION AND BIOLOGICAL ACTIVITIES OF RABBIT GAMMA M- AND GAMMA G-ANTI-SALMONELLA TYPHIMURIUM ANTIBODIES. J Exp Med. 1965 Aug 1;122:385–402. doi: 10.1084/jem.122.2.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. ROWLEY D. Rapidly induced changes in the level of non-specific immunity in laboratory animals. Br J Exp Pathol. 1956 Jun;37(3):223–234. [PMC free article] [PubMed] [Google Scholar]
  200. ROWLEY D. The virulence of strains of Bacterium coli for mice. Br J Exp Pathol. 1954 Dec;35(6):528–538. [PMC free article] [PubMed] [Google Scholar]
  201. ROWLEY D., WARDLAW A. C. Lysis of gram-negative bacteria by serum. J Gen Microbiol. 1958 Apr;18(2):529–533. doi: 10.1099/00221287-18-2-529. [DOI] [PubMed] [Google Scholar]
  202. Reed W. P., Albright E. L. Serum factors responsible for killing of Shigella. Immunology. 1974 Jan;26(1):205–215. [PMC free article] [PubMed] [Google Scholar]
  203. Reid K. B., Porter R. R. The proteolytic activation systems of complement. Annu Rev Biochem. 1981;50:433–464. doi: 10.1146/annurev.bi.50.070181.002245. [DOI] [PubMed] [Google Scholar]
  204. Reynard A. M., Beck M. E., Cunningham R. K. Effects of antibiotic resistance plasmids on the bactericidal activity of normal rabbit serum. Infect Immun. 1978 Mar;19(3):861–866. doi: 10.1128/iai.19.3.861-866.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Reynard A. M., Beck M. E. Plasmid-mediated resistance to the bactericidal effects of normal rabbit serum. Infect Immun. 1976 Sep;14(3):848–850. doi: 10.1128/iai.14.3.848-850.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Reynolds B. L., Pruul H. Sensitization of complement-resistant smooth gram-negative bacterial strains. Infect Immun. 1971 Mar;3(3):365–372. doi: 10.1128/iai.3.3.365-372.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Reynolds B. L., Rother U. A., Rother K. O. Interaction of complement components with a serum-resistant strain of Salmonella typhimurium. Infect Immun. 1975 May;11(5):944–948. doi: 10.1128/iai.11.5.944-948.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Reynolds B. L., Rowley D. Sensitization of complement resistant bacterial strains. Nature. 1969 Mar 29;221(5187):1259–1261. doi: 10.1038/2211259a0. [DOI] [PubMed] [Google Scholar]
  209. Rittenberg S. C., Penn C. W., Parsons N. J., Veale D. R., Smith H. Phenotypic changes in the resistance of Neisseria gonorrhoeae to killing by normal human serum. J Gen Microbiol. 1977 Nov;103(1):69–75. doi: 10.1099/00221287-103-1-69. [DOI] [PubMed] [Google Scholar]
  210. Roantree R. J., Rantz L. A. A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION. J Clin Invest. 1960 Jan;39(1):72–81. doi: 10.1172/JCI104029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Robbins J. B., McCracken G. H., Jr, Gotschlich E. C., Orskov F., Orskov I., Hanson L. A. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med. 1974 May 30;290(22):1216–1220. doi: 10.1056/NEJM197405302902202. [DOI] [PubMed] [Google Scholar]
  212. Root R. K., Ellman L., Frank M. M. Bactericidal and opsonic properties of C4-deficient guinea pig serum. J Immunol. 1972 Sep;109(3):477–486. [PubMed] [Google Scholar]
  213. Rottem S., Leive L. Effect of variations in lipopolysaccharide on the fluidity of the outer membrane of Escherichia coli. J Biol Chem. 1977 Mar 25;252(6):2077–2081. [PubMed] [Google Scholar]
  214. Rowley D. Antibacterial action of antibody and complement. J Infect Dis. 1973 Jul;128(Suppl):170–175. doi: 10.1093/infdis/128.supplement_1.s170. [DOI] [PubMed] [Google Scholar]
  215. Rowley D. Sensitivity of rough gram-negative bacteria to the bactericidal action of serum. J Bacteriol. 1968 May;95(5):1647–1650. doi: 10.1128/jb.95.5.1647-1650.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  216. Rowley D., Turner K. J. Passive sensitization of Salmonella adelaide to the bactericidal action of antibody and complement. Nature. 1968 Feb 17;217(5129):657–658. doi: 10.1038/217657a0. [DOI] [PubMed] [Google Scholar]
  217. SALTON M. R., GHUYSEN J. M. The structure of di- and tetrasaccharides released from cell walls by lysozyme and Streptomyces F 1 enzyme and the beta(1 to 4) N-acetylhexos-aminidase activity of these enzymes. Biochim Biophys Acta. 1959 Dec;36:552–554. doi: 10.1016/0006-3002(59)90205-7. [DOI] [PubMed] [Google Scholar]
  218. Sabet S. F. Effect of colicin K on a membrane-associated, energy-linked function. J Bacteriol. 1976 May;126(2):601–608. doi: 10.1128/jb.126.2.601-608.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Schiffer M. S., Oliveira E., Glode M. P., McCracken G. H., Jr, Sarff L. M., Robbins J. B. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli. Pediatr Res. 1976 Feb;10(2):82–87. doi: 10.1203/00006450-197602000-00002. [DOI] [PubMed] [Google Scholar]
  220. Schoolnik G. K., Buchanan T. M., Holmes K. K. Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera. J Clin Invest. 1976 Nov;58(5):1163–1173. doi: 10.1172/JCI108569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  221. Schreiber R. D., Morrison D. C., Podack E. R., Müller-Eberhard H. J. Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins. J Exp Med. 1979 Apr 1;149(4):870–882. doi: 10.1084/jem.149.4.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Schreiber R. D., Müller-Eberhard H. J. Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins. J Exp Med. 1978 Dec 1;148(6):1722–1727. doi: 10.1084/jem.148.6.1722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Schulkind M. L., Kenny K., Herzberg M., Robbins J. B. The specific secondary biological activities of rabbit IgM and IgG anti-Salmonella typhimurium 'O' antibodies isolated during the development of the immune response. Immunology. 1972 Aug;23(2):159–170. [PMC free article] [PubMed] [Google Scholar]
  224. Schwab G. E., Reeves P. R. Comparison of the bactericidal activity of different vertebrate sera. J Bacteriol. 1966 Jan;91(1):106–112. doi: 10.1128/jb.91.1.106-112.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Sevag M. G., Miller R. E. Studies on the Effect of Immune Reactions on the Metabolism of Bacteria: I. Methods and Results with Eberthella typhosa. J Bacteriol. 1948 Mar;55(3):381–392. [PMC free article] [PubMed] [Google Scholar]
  226. Shelton E., Yonemasu K., Stroud R. M. Ultrastructure of the human complement component, Clq (negative staining-glutamine synthetase-biologically active Clq). Proc Natl Acad Sci U S A. 1972 Jan;69(1):65–68. doi: 10.1073/pnas.69.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Shin M. L., Hänsch G., Mayer M. M. Effect of agents that produce membrane disorder on lysis of erythrocytes by complement. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2522–2525. doi: 10.1073/pnas.78.4.2522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Shin M. L., Paznekas W. A., Mayer M. M. On the mechanism of membrane damage by complement: the effect of length and unsaturation of the acyl chains in liposomal bilayers and the effect of cholesterol concentration in sheep erythrocyte and liposomal membranes. J Immunol. 1978 Jun;120(6):1996–2002. [PubMed] [Google Scholar]
  229. Silver R. P., Aaronson W., Sutton A., Schneerson R. Comparative analysis of plasmids and some metabolic characteristics of Escherichia coli K1 from diseased and healthy individuals. Infect Immun. 1980 Jul;29(1):200–206. doi: 10.1128/iai.29.1.200-206.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Silver R. P., Finn C. W., Vann W. F., Aaronson W., Schneerson R., Kretschmer P. J., Garon C. F. Molecular cloning of the K1 capsular polysaccharide genes of E. coli. Nature. 1981 Feb 19;289(5799):696–698. doi: 10.1038/289696b0. [DOI] [PubMed] [Google Scholar]
  231. Simberkoff M. S., Moldover N. H., Rahal J., Jr Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. A regional host defense deficiency. J Lab Clin Med. 1980 Mar;95(3):362–372. [PubMed] [Google Scholar]
  232. Simberkoff M. S., Ricupero I., Rahal J. J., Jr Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes. J Lab Clin Med. 1976 Feb;87(2):206–217. [PubMed] [Google Scholar]
  233. Sims P. J., Lauf P. K. Analysis of solute diffusion across the C5b-9 membrane lesion of complement: evidence that individual C5b-9 complexes do not function as discrete, uniform pores. J Immunol. 1980 Dec;125(6):2617–2625. [PubMed] [Google Scholar]
  234. Siroták L., Inoue K., Okada M., Amano T. Immune bactericidal reactions by guinea-pig gamma1 and gamma2 antibodies. Immunology. 1976 Mar;30(3):435–441. [PMC free article] [PubMed] [Google Scholar]
  235. Skarnes R. C. Humoral bactericidal systems: nonspecific and specific mechanisms. Infect Immun. 1978 Feb;19(2):515–522. doi: 10.1128/iai.19.2.515-522.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  236. Spink W. W., Keefer C. S. STUDIES OF GONOCOCCAL INFECTION. II. THE BACTERIOLYTIC POWER OF THE WHOLE DEFIBRINATED BLOOD OF PATIENTS WITH GONOCOCCAL ARTHRITIS. J Clin Invest. 1937 Mar;16(2):177–183. doi: 10.1172/JCI100845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Spitznagel J. K., Wilson L. A. Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. I. Loss of label, death, and ultrastructural damage. J Bacteriol. 1966 Jan;91(1):393–400. doi: 10.1128/jb.91.1.393-400.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  238. Stevens P., Huang S. N., Welch W. D., Young L. S. Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity. J Immunol. 1978 Dec;121(6):2174–2180. [PubMed] [Google Scholar]
  239. Steward J. P., Collis L. R., Roantree R. J. Effects of immunization of guinea pigs lacking bactericidal antibody against Salmonella enteritidis. J Immunol. 1966 Aug;97(2):224–230. [PubMed] [Google Scholar]
  240. Svehag S. E., Manhem L., Bloth B. Ultrastructure of human C1q protein. Nat New Biol. 1972 Jul 26;238(82):117–118. doi: 10.1038/newbio238117a0. [DOI] [PubMed] [Google Scholar]
  241. TACHIBANA D. K. CHARACTERIZATION OF THE BACTERICIDAL ACTION OF PRECOLOSTRAL PIGLET AND CALF SERA AGAINST GRAM NEGATIVE ENTERIC BACTERIA IN ROUGH PHASE. Folia Microbiol (Praha) 1965 May;10:145–155. doi: 10.1007/BF02881005. [DOI] [PubMed] [Google Scholar]
  242. TISDALE W. A. Spontaneous colon bacillus bacteremia in Laennec's cirrhosis. Gastroenterology. 1961 Jan;40:141–148. [PubMed] [Google Scholar]
  243. TURK J. L. Immunological activity of precolostral calf serum. Nature. 1959 Mar 21;183(4664):838–838. doi: 10.1038/183838a0. [DOI] [PubMed] [Google Scholar]
  244. Taylor P. W. An antibactericidal factor in the serum of two patients with infections of the upper urinary tract. Clin Sci. 1972 Jul;43(1):23–30. doi: 10.1042/cs0430023. [DOI] [PubMed] [Google Scholar]
  245. Taylor P. W., Gaunt H., Unger F. M. Effect of subinhibitory concentrations of mecillinam on the serum susceptibility of Escherichia coli strains. Antimicrob Agents Chemother. 1981 May;19(5):786–788. doi: 10.1128/aac.19.5.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. Taylor P. W. Genetical studies of serum resistance in Escherichia coli. J Gen Microbiol. 1975 Jul;89(1):57–66. doi: 10.1099/00221287-89-1-57. [DOI] [PubMed] [Google Scholar]
  247. Taylor P. W., Hughes C. Plasmid carriage and the serum sensitivity of enterobacteria. Infect Immun. 1978 Oct;22(1):10–17. doi: 10.1128/iai.22.1.10-17.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  248. Taylor P. W. Immunochemical investigations on lipopolysaccharides and acidic polysaccharides from serum-sensitive and serum-resistant strains of Escherichia coli isolated from urinary-tract infections. J Med Microbiol. 1976 Nov;9(4):405–421. doi: 10.1099/00222615-9-4-405. [DOI] [PubMed] [Google Scholar]
  249. Taylor P. W. Isolation and characterization of a serum antibactericidal factor. Clin Sci. 1972 Nov;43(5):705–708. doi: 10.1042/cs0430705. [DOI] [PubMed] [Google Scholar]
  250. Taylor P. W., Koutsaimanis K. G. Experimental Escherichia coli urinary infection in the rat. Kidney Int. 1975 Oct;8(4):233–238. doi: 10.1038/ki.1975.106. [DOI] [PubMed] [Google Scholar]
  251. Taylor P. W., Kroll H. P. Killing of an encapsulated strain of Escherichia coli by human serum. Infect Immun. 1983 Jan;39(1):122–131. doi: 10.1128/iai.39.1.122-131.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  252. Taylor P. W., Messner P., Parton R. Effect of the growth environment on cell-envelope components of Escherichia coli in relation to sensitivity to human serum. J Med Microbiol. 1981 Feb;14(1):9–19. doi: 10.1099/00222615-14-1-9. [DOI] [PubMed] [Google Scholar]
  253. Taylor P. W., Parton R. A protein factor associated with serum resistance in Escherichia coli. J Med Microbiol. 1977 May;10(2):225–232. doi: 10.1099/00222615-10-2-225. [DOI] [PubMed] [Google Scholar]
  254. Taylor P. W., Roberts A. P., Gower P. E. Evaluation of a technique for the estimation of serum bactericidal activity against Gram-negative organisms. Med Lab Technol. 1972 Jul;29(3):272–279. [PubMed] [Google Scholar]
  255. Taylor P. W., Robinson M. K. Determinants that increase the serum resistance of Escherichia coli. Infect Immun. 1980 Jul;29(1):278–280. doi: 10.1128/iai.29.1.278-280.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  256. Taylor P. W. Sensitivity of some smooth strains of Escherichia coli to the bactericidal action of normal human serum. J Clin Pathol. 1974 Aug;27(8):626–629. doi: 10.1136/jcp.27.8.626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  257. Tempest D. W., Ellwood D. C. The influence of growth conditions on the composition of some cell wall components of Aerobacter aerogenes. Biotechnol Bioeng. 1969 Sep;11(5):775–783. doi: 10.1002/bit.260110507. [DOI] [PubMed] [Google Scholar]
  258. Teuber M. Susceptibility to polymyxin B in penicillin G-induced Proteus mirabilis L forms and spheroplasts. J Bacteriol. 1969 May;98(2):347–350. doi: 10.1128/jb.98.2.347-350.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  259. Thjøtta T., Waaler E. Dissociation and Sensitiveness to Normal Serum in Dysentery Bacilli of Type III. J Bacteriol. 1932 Oct;24(4):301–316. doi: 10.1128/jb.24.4.301-316.1932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  260. Thompson R. A., Lachmann P. J. Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J Exp Med. 1970 Apr 1;131(4):629–641. doi: 10.1084/jem.131.4.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. Tramont E. C., Sadoff J. C., Artenstein M. S. Cross-reactivity of Neisseria gonorrhoeae and Neisseria meningitidis and the nature of antigens involved in the bactericidal reaction. J Infect Dis. 1974 Sep;130(3):240–247. doi: 10.1093/infdis/130.3.240. [DOI] [PubMed] [Google Scholar]
  262. Tranum-Jensen J., Bhakdi S., Bhakdi-Lehnen B., Bjerrum O. J., Speth V. Complement lysis: the ultrastructure and orientation of the C5b-9 complex on target sheep erythrocyte membranes. Scand J Immunol. 1978;7(1):45–46. doi: 10.1111/j.1365-3083.1978.tb00425.x. [DOI] [PubMed] [Google Scholar]
  263. Traub W. H., Kleber I. Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens. Infect Immun. 1976 May;13(5):1343–1346. doi: 10.1128/iai.13.5.1343-1346.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  264. Troy F. A., 2nd The chemistry and biosynthesis of selected bacterial capsular polymers. Annu Rev Microbiol. 1979;33:519–560. doi: 10.1146/annurev.mi.33.100179.002511. [DOI] [PubMed] [Google Scholar]
  265. Trust T. J., Courtice I. D., Khouri A. G., Crosa J. H., Schiewe M. H. Serum resistance and hemagglutination ability of marine vibrios pathogenic for fish. Infect Immun. 1981 Dec;34(3):702–707. doi: 10.1128/iai.34.3.702-707.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  266. Tschopp J., Podack E. R. Membranolysis by the ninth component of human complement. Biochem Biophys Res Commun. 1981 Jun 16;100(3):1409–1414. doi: 10.1016/0006-291x(81)91981-1. [DOI] [PubMed] [Google Scholar]
  267. Van Dijk W. C., Verbrugh H. A., Peters R., Van Der Tol M. E., Peterson P. K., Verhoef J. Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis. J Med Microbiol. 1979 Feb;12(1):123–130. doi: 10.1099/00222615-12-1-123. [DOI] [PubMed] [Google Scholar]
  268. Vosti K. L., Randall E. Sensitivity of serologically classified strains of escherichia coli of human origin to the serum bactericidal system. Am J Med Sci. 1970 Feb;259(2):114–119. doi: 10.1097/00000441-197002000-00005. [DOI] [PubMed] [Google Scholar]
  269. WARDLAW A. C., PILLEMER L. The properdin system and immunity. V. The bactericidal activity of the properdin system. J Exp Med. 1956 May 1;103(5):553–575. doi: 10.1084/jem.103.5.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  270. WARDLAW A. C. The complement-dependent bacteriolytic activity of normal human serum. I. The effect of pH and ionic strength and the role of lysozyme. J Exp Med. 1962 Jun 1;115:1231–1249. doi: 10.1084/jem.115.6.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  271. WEIDANZ W. P., JACKSON A. L., LANDY M. SOME ASPECTS OF THE ANTIBODY RESPONSE OF RABBITS TO IMMUNIZATION WITH ENTEROBACTERIAL SOMATIC ANTIGENS. Proc Soc Exp Biol Med. 1964 Jul;116:832–837. doi: 10.3181/00379727-116-29386. [DOI] [PubMed] [Google Scholar]
  272. Waisbren B. A., Brown I. A factor in the serum of patients with persisting infection that inhibits the bactericidal activity of normal serum against the organism that is causing the infection. J Immunol. 1966 Sep;97(3):431–437. [PubMed] [Google Scholar]
  273. Weiss M. J., Luria S. E. Reduction of membrane potential, an immediate effect of colicin K. Proc Natl Acad Sci U S A. 1978 May;75(5):2483–2487. doi: 10.1073/pnas.75.5.2483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  274. Wendt L. Mechanism of colicin action: early events. J Bacteriol. 1970 Dec;104(3):1236–1241. doi: 10.1128/jb.104.3.1236-1241.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Wilson L. A., Spitznagel J. K. Characteristics of complement-dependent release of phospholipid from Escherichia coli. Infect Immun. 1971 Jul;4(1):23–28. doi: 10.1128/iai.4.1.23-28.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  276. Wilson L. A., Spitznagel J. K. Molecular and structural damage to Escherichia coli produced by antibody, complement, and lysozyme systems. J Bacteriol. 1968 Oct;96(4):1339–1348. doi: 10.1128/jb.96.4.1339-1348.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  277. Wright S. D., Levine R. P. How complement kills E. coli. I. Location of the lethal lesion. J Immunol. 1981 Sep;127(3):1146–1151. [PubMed] [Google Scholar]
  278. Wright S. D., Levine R. P. How complement kills E. coli. II. The apparent two-hit nature of the lethal event. J Immunol. 1981 Sep;127(3):1152–1156. [PubMed] [Google Scholar]
  279. Young L. S., Armstrong D. Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. J Infect Dis. 1972 Sep;126(3):257–276. doi: 10.1093/infdis/126.3.257. [DOI] [PubMed] [Google Scholar]
  280. Zinner S. H., McCabe W. R. Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli. J Infect Dis. 1976 Jan;133(1):37–45. doi: 10.1093/infdis/133.1.37. [DOI] [PubMed] [Google Scholar]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES